O'Neill Institute

O'Neill Institute for National & Global Health Law - Summer Programs 2014

O'Neill Institute
O'Neill Institute

2014 Summer Program

Food and Drug Law

July 14-18, 2014
 
O'Neill Institute

Summer Program on Emerging Issues
in Food and Drug Law

Please join the O’Neill Institute for National and Global Health Law at Georgetown University for a one-week intensive summer institute exploring the domestic and international legal, regulatory, and policy framework shaping the safety and availability of foods and medicines worldwide. 

Important Dates

June 15
Application Deadline

Program Details

Program Fees

Regular Attendees

Middle/Low-income Countries:
$1,825 ($3,150)  

High-income Countries:
$2,500 ($4,485)

Government and Academic Attendees
(Current government officials, students, post-docs, and non-tenured faculty)


Middle/Low-income Countries:

$1,575 ($2,650)

High-income Countries:
$2,250 ($3,985)


**Prices in parentheses are the costs for attending both summer programs (O'Neill Institute Summer Program on US Health Reform - The Affordable Care Act - July 21-25, 2014)

CLE Credit
CLE credits are available to attorneys admitted to a United States state bar. CLE accreditation is on a state-by-state basis.

Travel & Housing
Participants are responsible for arranging their own travel and housing.  A short list of area hotels can be found here.

Certificate of Attendance
Participants will receive a Certificate of Attendance from Georgetown University Law Center upon completion of the Summer Program.

Cancellation Policy
Registration cancellations and requests for refunds must be received in writing to oneillsummer@law.georgetown.edu by Friday, June 13, 2014.

All refund requests will be charged a $100 administrative handling fee and will be processed after the conference. 

Helpful Links

Application
Listserv 
More Information
 


 



 



 


 
FDA Commissioner Margaret Hamburg, MD to be Key Note Speaker

Margaret A. Hamburg became the 21st commissioner of food and drugs on May 18, 2009. The second woman to be nominated for this position, she is an experienced medical doctor, scientist, and public health executive.

As the top official of the Food and Drug Administration (FDA), Dr. Hamburg is committed to strengthening programs and policies that enable the agency to carry out its mission to protect and promote the public health. “Strengthening FDA’s programs and policies will help us protect the safety of the food supply, give the public access to safe and effective medical products, find novel ways to prevent illness and promote health, and be transparent in explaining our decision-making,” says Dr. Hamburg. “A strong FDA is an agency that the American public can count on.”

Dr. Hamburg graduated from Harvard Medical School and completed her residency in internal medicine at what is now New York–Presbyterian Hospital/Weill Cornell Medical Center. She conducted research on neuroscience at Rockefeller University, studied neuropharmacology at the National Institute of Mental Health, and later focused on AIDS research as assistant director of the National Institute of Allergy and Infectious Diseases.

Director

Professor Sam Halabi (HAL uh bee), J.D., M.Phil., is an O'Neill Institute Scholar and an Associate Professor at the University of Tulsa College of Law. From 2008 to 2010, he was a law fellow at the O’Neill Institute for National and Global Health Law and an adjunct professor of law at Georgetown University Law Center.  He is a member of the Editorial Advisory Board of the Food and Drug Law Journal as well as the American Society of Law, Medicine, and Ethics.  Before joining O’Neill, Prof. Halabi was an associate at Latham & Watkins, LLP.  He earned his J.D. from Harvard Law School and an M.Phil. from the University of Oxford (St. Antony's College).

Confirmed Speakers 

Alberto Alemanno
Jean Monnet Professor of EU Law and Risk Regulation, HEC-Paris
Scholar, O’Neill Institute for National and Global Health Law

Jodi Avergun
Partner, Cadwalader

Ilisa B.G. Bernstein 
Deputy Director, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Parth Chanda
Senior Corporate Counsel, Compliance, Pfizer Pharmaceuticals

Philip Chen
Assistant General Counsel, Office of the US Trade Representative 

Katherine Cooper
Senior Policy and Strategy Analyst, Office of Strategy, Partnerships, and Analytics, Office of International Programs, U.S. Food and Drug Administration

Sandra Eskin
Director, Food Safety, The Pew Charitable Trusts

James Fitzgerald
Director of Health Systems and Services, PAHO/WHO

Michele Forzley
Senior Scholar and Careers and Externships Advisor, O'Neill Institute for National and Global Health Law
Distinguished Visiting Scholar, Health Law Institute, Widener University School of Law

Bruce Gellin
Deputy Assistant Secretary for Health; Director, National Vaccine Program Office, HHS

Aliza Glasner
Institute Associate, O'Neill Institute for National and Global Health Law

Ariel Glasner
Associate, Blank Rome, LLP

Jesse Goodman
Director, Center on Medical Product Access, Safety and Stewardship (COMPASS), Georgetown University Medical Center
Former Chief Scientist, US Food and Drug Administration

Jeffrey Gren
Board Member, Alliance for Safe Online Pharmacies; President, Gren International Health & Trade Consulting; and Former Director, U.S. Department of Commerce, Office of Health and Information Technology

Ben Haas
Partner, Latham & Watkins 

Sabine Haubenreisser
Officer for External Communications and Media, European Medicines Agency; Former Specialised Group Leader of the Team Anti-Infectives, Immunology, Gastroenterology and Musculoskeletal in the Post-Authorisation Human Unit

Lisa Heinzerling
William J. Brennan, Jr. Professor of Law, Georgetown University Law Center  
Former Associate Administrator, US Environmental Protection Agency Office of Policy, 2009-10

Susan C. Kim
Deputy Director, O'Neill Institute for National and Global Health Law

Benn McGrady
Project Director, Trade, Investment and Health Initiative, O'Neill Institute for National and Global Health Law
Adjunct Professor, Georgetown University Law Center

John Monahan
Senior Advisor to the President for Global Health and Senior Fellow, McCourt School of Public Policy, Georgetown University
Former Counselor to the Secretary and Director, Office of Global Health Affairs, US Department of Health and Human Services (HHS)

Joseph Page
Professor of Law, Georgetown University Law Center 
Director, Center for the Advancement of the Rule of Law in the Americas

Gordon Schatz
Asia Integration Partner, Life Sciences Health Industry Group, Reed Smith, LLP

Marc Scheineson
Partner, Chair, Food and Drug Law Practice Group, Alston & Bird, LLP

Doug Stearn
Deputy Director Policy and Analysis, US Food and Drug Administration

David Vladeck
Professor of Law, Georgetown University Law Center 
Former Director of the Bureau of Consumer Protection, Federal Trade Commission 

Chris Waldrop
Director, Food Policy Institute, Consumer Federation of America

Susan Weld
Executive Director, Law Asia Leadership, Adjunct Professor of Law, Georgetown University Law Center

Timothy Westmoreland
Professor of Practice, Georgetown University Law Center
Former Counsel to the Subcommittee on Health and the Environment, US Health of Representatives

Samuel R. Wiseman
Assistant Professor, Florida State University College of Law 


Derek Yach
Senior Vice President of the Vitality Group 
Former Executive Director for Noncommunicable Diseases and Mental Health, World Health Organization

Jennifer Zachary
Partner, Food and Drug Practice Group, Covington and Burling, LLP

Ed Zhao
Vice President, Business Development and Allied Compendial Programs, U.S. Pharmacopeial Convention (USP)

Copyright © 2014 The O’Neill Institute for National and Global Health Law at Georgetown University. All rights reserved.

Blog  Facebook  Twitter  RSS

 unsubscribe from this list | update subscription preferences